Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

Abstract

NAFLD is common in PCOS patients and increased androgen bioavailability may be implicated, in combination with metabolic abnormalities. Liver evaluation is proposed in PCOS patients, especially in those with metabolic syndrome.